Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

MP-08.18

P. Iversen,H. Van Poppel,T. Tammela,J. de la Rosette, J.E. Johansson,B.E. Persson,J.K. Jensen,T.K. Olesen

Urology（2006）

Cited 1|Views21
No score
Abstract
Degarelix is a gonadotropin-releasing hormone (GnRH) blocker with an immediate onset of action that produces fast, profound and sustained suppression of serum testosterone (T) levels, without T surge. International, multicentre, phase II studies were performed to determine the optimal initiation dose (studies 1 and 2) and maintenance dose (study 2) of Degarelix for hormonal therapy of prostate cancer (CaP).
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined